Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1

Conditions

Neoplasms 2Prostatic Neoplasms 1Hereditary Cancer 1Adenocarcinoma 1

Interventions

pembrolizumab 1280Specimen Handling 928Carboplatin 836Magnetic Resonance Spectroscopy 831Cyclophosphamide 807Cisplatin 735Nivolumab 679Paclitaxel 634Radiotherapy 617Gemcitabine 579Biopsy 560Bevacizumab 486Dexamethasone 444fludarabine 409Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 363Fluorouracil 358atezolizumab 353durvalumab 339Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 320Blood Specimen Collection 315Standard of Care 311Pemetrexed 308Ipilimumab 303Radiation 289

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Longitudinal Studies × 1 year × Clear all
NCT06157801 2026-03-04

Evaluation of Hereditary Cancer Educational Videos

M.D. Anderson Cancer Center

Active not recruiting
43 enrolled

Hereditary Cancer

NCT07339943 2026-01-14

MicroUSgFLA

University Health Network, Toronto

Phase NA Recruiting
7 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06270602 2025-12-22

The ONCOCAMP Study

National Cancer Institute, Naples

Recruiting
15,000 enrolled
Tumor-Agnostic

Neoplasms

NCT02159742 2025-07-02

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Abramson Cancer Center at Penn Medicine

Active not recruiting
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡